From Financial Modeling Prep: 2024-11-18 12:21:00 Piper Sandler analysts lowered Moderna’s price target to $69 but maintained an Overweight rating,
From Financial Modeling Prep: 2024-11-18 12:16:00 Piper Sandler analysts raised Robinhood Markets’ price target from $30 to $36 with an
From Financial Modeling Prep: 2024-11-18 12:14:00 Baird analysts maintain Neutral rating and $235 price target on Dick’s Sporting Goods (NYSE:DKS).
From Financial Modeling Prep: 2024-11-18 04:00:03 Golar LNG Limited (NASDAQ:GLNG) is a key player in the LNG industry, focusing on
From Financial Modeling Prep: 2024-11-18 02:00:03 Jacobs Solutions Inc. (NYSE:J) is set to report quarterly earnings on November 19, 2024,
From Financial Modeling Prep: 2024-11-18 00:00:03 Walmart (NYSE:WMT) will announce Q3 2025 earnings with an expected EPS of $0.53 and
From None.: 2024-11-17 16:00:06 In the financial sector, John Marshall Bancorp, Inc. (NASDAQ:JMSB) demonstrates strong capital efficiency with a ROIC
From Financial Modeling Prep: 2024-11-17 16:00:05 JPMorgan Chase & Co. has a ROIC of 7.84% and a WACC of 11.58%,
From Financial Modeling Prep: 2024-11-17 16:00:01 The consensus price target for AECOM (NYSE: ACM) has increased to $128 from $123.5,
From Financial Modeling Prep: 2024-11-17 14:00:04 Westlake Corporation, a chemical company based in Houston, has declared a dividend of $0.525
From Financial Modeling Prep: 2024-11-17 07:00:01 Analyst price target for NASDAQ:TCOM has increased from $69.49 a year ago to $85
From Financial Modeling Prep: 2024-11-16 21:00:03 In Q3 2024, Origin Materials, Inc. reported an EPS of -$0.26, missing the expected
From Financial Modeling Prep: 2024-11-16 16:00:04 Agenus Inc. (NASDAQ:AGEN) excels in capital efficiency with a 302.53% ROIC and 80.76% WACC.
From Financial Modeling Prep: 2024-11-15 08:00:00 Applied Materials (NASDAQ:AMAT) exceeded expectations for Q4 with adjusted EPS of $2.32 and revenue
From Financial Modeling Prep: 2024-11-15 07:56:00 Globant S.A. (NYSE:GLOB) shares dropped over 3% in pre-market despite meeting analyst expectations in
From None: 2024-11-15 07:53:00 JPMorgan analysts downgraded bluebird bio (NASDAQ:BLUE) to Underweight due to financial challenges and limited capital-raising options
From Barchart: 2024-11-15 07:47:00 Goldman Sachs analysts started coverage on Doximity (NYSE:DOCS) with a Neutral rating and a price target
From Barchart: 2024-11-15 07:37:00 Guggenheim analysts reiterated a Buy rating and $23 price target for Cabaletta Bio (NASDAQ:CABA) after positive
From Financial Modeling Prep: 2024-11-15 07:28:00 CFRA analysts downgraded Advance Auto Parts (NYSE:AAP) from Hold to Sell, with a new
From Financial Modeling Prep: 2024-11-15 02:00:45 The Federal Reserve is focused on economic strength and achieving sustainable 2% inflation before
From Barchart: 2024-11-15 02:00:07 Bitcoin’s price has risen near $90,000, fueled by positive market sentiment and a boost from Donald
From Barchart: 2024-11-15 01:59:26 Bitcoin has surged to nearly $90,000, driven by market optimism and support from Donald Trump’s campaign
From Barchart: 2024-11-15 01:58:31 The S&P 500 index is showing strong growth, but concerns about overvaluation persist. The high P/E
From Financial Modeling Prep: 2024-11-15 01:57:46 The S&P 500, representing over 50% of the global equity market, showcases the dominance
From Financial Modeling Prep: 2024-11-15 01:57:00 Tesla’s stock surge prompts Jefferies analysts to recommend a capital raise to strengthen the